Simbol EDIT | |
Simbol | EDIT |
Simbol eToro | EDIT |
MarketWatch | EDIT |
Finviz | EDIT |
Yahoo Finance | EDIT |
Google Finance | EDIT |
TradingView | EDIT |
Investing.com | EDIT |
Wikipedia | Editas Medicine |
Denumire | Editas Medicine Inc. |
Website | editasmedicine.com |
Piața | NASDAQ |
ISIN | US28106W1036 |
Sector | Health Technology |
Industrie | Biotechnology |
Monedă | USD |
Preț | 8,8000 USD |
Capitalizare bursieră | 0,609 mld. USD |
P/E | -2,77 |
Beta | 2,0571 |
EPS | -3,1838 |
Profit anual | -22,01% |
Dată actualizare | 16.06.2023 |
Descriere |
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |
Data | P/E | Beta | Capitalizare | Dividend | EPS | Profit anual | Preț |
19.09.2021 | 0,00 | 1,5045 | 4,310 | 0,00% | 0,0000 | +95,54% | $0,00 |
16.06.2023 | -2,77 | 2,0571 | 0,609 | 0,00% | -3,1838 | -22,01% | $8,80 |